Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific

International Journal of Food Microbiology

Volumn 144, Issue 1, 2010, Pages 133-140

  Stöber, Helen ^a   Maier, Eva ^a   Schmidt, Herbert ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

Enterohemorrhagic E. coli; IL 8; Lactic acid bacteria; NF B; Probiotics

Indexed keywords

ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIFIDOBACTERIUM ADOLESCENTIS; CANCER CELL; CELL CULTURE; COLON ADENOCARCINOMA; CYTOKINE PRODUCTION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS HELVETICUS; LACTOBACILLUS JOHNSONII; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARALIMENTARIUS; MIXED INFECTION; MOLECULAR INTERACTION; STAPHYLOCOCCUS; VIRULENCE;

ACIDS; BACTERIAL ADHESION; BIFIDOBACTERIUM; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION REGULATION; HT29 CELLS; HUMANS; INTERLEUKIN-8; LACTOBACILLUS; NF-KAPPA B; PROBIOTICS; SPECIES SPECIFICITY; STAPHYLOCOCCUS;

ESCHERICHIA COLI; STAPHYLOCOCCUS;

EID: 78149471106     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.09.010     Document Type: Article

References (50)

1. Asahara T., Shimizu K., Nomoto K., Hamabata T., Ozawa A., Takeda Y. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect. Immun. 2004, 72:2240-2247.
2. Berin M.C., Darfeuille-Michaud A., Egan L.J., Miyamoto Y., Kagnoff M.F. Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. Cell. Microbiol. 2002, 4:635-648.
3. Bielaszewska M., Sinha B., Kuczius T., Karch H. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 2005, 73:552-562.
4. Bjorland J., Bratlie M.S., Steinum T. The smr gene resides on a novel plasmid pSP187 identified in a Staphylococcus pasteuri isolate recovered from unpasteurized milk. Plasmid 2007, 57:145-155.
5. Carey C.M., Kostrzynska M., Ojha S., Thompson S. The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J. Microbiol. Meth. 2008, 73:125-132.
6. Ceponis P.J., Riff J.D., Sherman P.M. Epithelial cell signaling responses to enterohemorrhagic Escherichia coli infection. Mem. Inst. Oswaldo Cruz 2005, 100(Suppl 1):199-203.
7. Chesneau O., Morvan A., Grimont F., Labischinski H., el Solh N. Staphylococcus pasteuri sp. nov., isolated from human, animal, and food specimens. Int. J. Syst. Bacteriol. 1993, 43:237-244.
8. Creuzburg K., Schmidt H. Molecular characterization and distribution of genes encoding members of the type III effector nleA family among pathogenic Escherichia coli strains. J. Clin. Microbiol. 2007, 45:2498-2507.
9. Croxen M.A., Finlay B.B. Molecular mechanisms of Escherichia coli pathogenicity. Nat. Rev. Microbiol. 2010, 8:26-38.
10. Dahan S., Busuttil V., Imbert V., Peyron J.F., Rampal P., Czerucka D. Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells. Infect. Immun. 2002, 70:2304-2310.
11. FAO/WHO Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultant Report 2001, 1-34.
12. Frick J.S., Fink K., Kahl F., Niemiec M.J., Quitadamo M., Schenk K., Autenrieth I.B. Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics. Infect. Immun. 2007, 75:3490-3497.
13. Frick J.S., Schenk K., Quitadamo M., Kahl F., Koberle M., Bohn E., Aepfelbacher M., Autenrieth I.B. Lactobacillus fermentum attenuates the proinflammatory effect of Yersinia enterocolitica on human epithelial cells. Inflamm. Bowel Dis. 2007, 13:83-90.
14. Friedrich A.W., Lu S., Bielaszewska M., Prager R., Bruns P., Xu J.G., Tschape H., Karch H. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 2006, 44:1844-1846.
15. Gao X., Wan F., Mateo K., Callegari E., Wang D., Deng W., Puente J., Li F., Chaussee M.S., Finlay B.B., Lenardo M.J., Hardwidge P.R. Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog. 2009, 5:e1000708.
16. Gobert A.P., Coste A., Guzman C.A., Vareille M., Hindre T., de Sablet T., Girardeau J.P., Martin C. Modulation of chemokine gene expression by Shiga-toxin producing Escherichia coli belonging to various origins and serotypes. Microbes Infect. 2008, 10:159-165.
17. Goldwater P.N. Treatment and prevention of enterohemorrhagic Escherichia coli infection and hemolytic uremic syndrome. Expert Rev. Anti. Infect. Ther. 2007, 5:653-663.
18. Guessous F., Marcinkiewicz M., Polanowska-Grabowska R., Kongkhum S., Heatherly D., Obrig T., Gear A.R. Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function. Infect. Immun. 2005, 73:8306-8316.
19. Hauf, N., Chakraborty, T., 15-2-2003. Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli. J.Immunol. 170,2074-2082.
20. Higgins S.E., Higgins J.P., Wolfenden A.D., Henderson S.N., Torres-Rodriguez A., Tellez G., Hargis B. Evaluation of a Lactobacillus-based probiotic culture for the reduction of Salmonella enteritidis in neonatal broiler chicks. Poult. Sci. 2008, 87:27-31.
21. Hirano J., Yoshida T., Sugiyama T., Koide N., Mori I., Yokochi T. The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol. Immunol. 2003, 47:405-409.
22. House B., Kus J.V., Prayitno N., Mair R., Que L., Chingcuanco F., Gannon V., Cvitkovitch D.G., Barnett Foster D. Acid-stress-induced changes in enterohaemorrhagic Escherichia coli O157: H7 virulence. Microbiology 2009, 155:2907-2918.
23. Iacumin L., Comi G., Cantoni C., Cocolin L. Ecology and dynamics of coagulase-negative cocci isolated from naturally fermented Italian sausages. Syst. Appl. Microbiol. 2006, 29:480-486.
24. - and O157:H7: characterization and evolutionary considerations. Infect. Immun. 2003, 71:3634-3638.
25. Jobin C., Sartor R.B. The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am. J. Physiol. Cell Physiol. 2000, 278:C451-C462.
26. Johnson-Henry K.C., Hagen K.E., Gordonpour M., Tompkins T.A., Sherman P.M. Surface-layer protein extracts from Lactobacillus helveticus inhibit enterohaemorrhagic Escherichia coli O157:H7 adhesion to epithelial cells. Cell. Microbiol. 2007, 9:356-367.
27. Johnson-Henry K.C., Donato K.A., Shen-Tu G., Gordanpour M., Sherman P.M. Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect. Immun. 2008, 76:1340-1348.
28. Kaper J.B. The locus of enterocyte effacement pathogenicity island of Shiga toxin-producing Escherichia coli O157:H7 and other attaching and effacing E. coli. Jpn J. Med. Sci. Biol. 1998, 51:S101-S107. Suppl.
29. Kim Y., Kim S.H., Whang K.Y., Kim Y.J., Oh S. Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J. Microbiol. Biotechnol. 2008, 18:1278-1285.
30. Lebeer S., Vanderleyden J., De Keersmaecker S.C. Genes and molecules of lactobacilli supporting probiotic action. Microbiol. Mol. Biol. Rev. 2008, 72:728-764. Table.
31. Lee Y.K., Puong K.Y., Ouwehand A.C., Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. J. Med. Microbiol. 2003, 52:925-930.
32. Mariani-Kurkdjian P., Denamur E., Milon A., Picard B., Cave H., Lambert-Zechovsky N., Loirat C., Goullet P., Sansonetti P.J., Elion J. Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J. Clin. Microbiol. 1993, 31:296-301.
33. Miyazaki, Y., Kamiya, S., Hanawa, T., Fukuda, M., Kawakami, H., Takahashi, H., Yokota, H., 7-1-2010. Effect of probiotic bacterial strains of Lactobacillus, Bifidobacterium, and Enterococcus on enteroaggregative Escherichia coli. J.Infect.Chemother.
34. Nandakumar N.S., Pugazhendhi S., Madhu Mohan K., Jayakanthan K., Ramakrishna B.S. Effect of Vibrio cholerae on chemokine gene expression in HT29 cells and its modulation by Lactobacillus GG. Scand. J. Immunol. 2009, 69:181-187.
35. Nataro J.P., Kaper J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11:142-201.
36. Noris M., Remuzzi G. Hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2005, 16:1035-1050.
37. O'Brien, A. D., Newland, J. W., Miller, S. F., Holmes, R. K., Smith, H. W., Formal, S. B., 9-11-1984. Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 226,694-696.
38. O'Loughlin E.V., Robins-Browne R.M. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect. 2001, 3:493-507.
39. Petrof E.O., Kojima K., Ropeleski M.J., Musch M.W., Tao Y., De Simone C., Chang E.B. Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 2004, 127:1474-1487.
40. Rangel J.M., Sparling P.H., Crowe C., Griffin P.M., Swerdlow D.L. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg. Infect. Dis. 2005, 11:603-609.
41. Scheiring J., Rosales A., Zimmerhackl L.B. Clinical practice. Today's understanding of the haemolytic uraemic syndrome. Eur. J. Pediatr. 2010, 169:7-13.
42. Schulte R., Autenrieth I.B. Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation. Infect. Immun. 1998, 66:1216-1224.
43. Sherman P.M., Johnson-Henry K.C., Yeung H.P., Ngo P.S., Goulet J., Tompkins T.A. Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect. Immun. 2005, 73:5183-5188.
44. Slanec T., Fruth A., Creuzburg K., Schmidt H. Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxin-producing Escherichia coli. Appl. Environ. Microbiol. 2009, 75:6187-6197.
45. Smigic N., Rajkovic A., Antal E., Medic H., Lipnicka B., Uyttendaele M., Devlieghere F. Treatment of Escherichia coli O157:H7 with lactic acid, neutralized electrolyzed oxidizing water and chlorine dioxide followed by growth under sub-optimal conditions of temperature, pH and modified atmosphere. Food Microbiol. 2009, 26:629-637.
46. Sterr, Y., Weiss, A., Schmidt, H., 15-9-2009. Evaluation of lactic acid bacteria for sourdough fermentation of amaranth. Int.J.Food Microbiol.
47. Taylor C.M. Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome. Pediatr. Nephrol. 2008, 23:1425-1431.
48. Thorpe C.M., Hurley B.P., Lincicome L.L., Jacewicz M.S., Keusch G.T., Acheson D.W. Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells. Infect. Immun. 1999, 67:5985-5993.
49. Toki S., Kagaya S., Shinohara M., Wakiguchi H., Matsumoto T., Takahata Y., Morimatsu F., Saito H., Matsumoto K. Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int. Arch. Allergy Immunol. 2009, 148:45-58.
50. Westerholt S., Hartung T., Tollens M., Gustrau A., Oberhoffer M., Karch H., Klare B., Pfeffer K., Emmrich P., Oberhoffer R. Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and gastroenteritis-pathophysiological and diagnostic clues. Cytokine 2000, 12:822-827.